Chemo India Formulation Private Limited, a active foreign private limited company, was established on 13 August 2015 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U85100TG2015FTC100239. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹130.00 Cr and a paid-up capital of ₹122.36 Cr.
It upholds a compliant status. Employing 225 professional, Its leadership includes Maria Sandra Martin Moran (Director), Bharat Vasudevan (Director), Manuel Ignacio Barro (Director). Past directors included Jaya Gopaldas Ahuja, Bharat Vasudevan, Shubham Girishbhai Barot. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 2B & 2C, Biotech Park, Phase Ii, Lalgadi Malakpet, Hyderabad, Hyderabad, Telangana, 500078.
U85100TG2015FTC100239
100239
13 August 2015
₹130.00 Cr
₹122.36 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Chemo India Formulation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maria Sandra Martin Moran | Director | 13 Aug 2015 | Current |
| Bharat Vasudevan | Director | 06 Jun 2019 | Current |
| Manuel Ignacio Barro | Director | 06 Jun 2019 | Current |
| Ramachandra Kumar Kurumaddali | Managing Director | 13 Aug 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Managing Director | 27 Sep 2021 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Chemo India Formulation Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.56% increase. The company also saw a substantial improvement in profitability, with a 19.27% increase in profit. The company's net worth moved up by a moderate rise of 4.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Chemo India Formulation had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Chemo India Formulation has a workforce of 225 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Chemo India Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemo India Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Chemo India Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Chemo India Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
The activity Bharat Vasudevan was appointed as a Director was appointed as a Director on 06 Jun 2019 & has been associated with this company since 6 years 7 months . was completed.
Progress on Manuel Ignacio Barro was appointed as a Director was appointed as a Director on 06 Jun 2019 & has been associated with this company since 6 years 7 months . was documented.
Maria Sandra Martin Moran was appointed as a Director was appointed as a Director on 13 Aug 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.
Ramachandra Kumar Kurumaddali was appointed as a Managing Director was appointed as a Managing Director on 13 Aug 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.
The CIN of Chemo India Formulation Private Limited is U85100TG2015FTC100239.
Chemo India Formulation Private Limited is headquartered at Plot No. 2B & 2C, Biotech Park, Phase Ii, Lalgadi Malakpet, Hyderabad, Hyderabad, Telangana, 500078.
Chemo India Formulation Private Limited was incorporated on 13 August 2015.
The current directors of Chemo India Formulation Private Limited are
The primary industry of Chemo India Formulation Private Limited is Professional, Scientific And Technical.
Chemo India Formulation Private Limited is unlisted.
The authorized capital of Chemo India Formulation Private Limited is ₹130.00 Cr, and the paid-up capital is ₹122.36 Cr.
The compliance status of Chemo India Formulation Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX